HBVAXPRO sol inj 40 mcg dialyse flac 1 ml
7680005450012
CH-545
J07BC01
08.08.
1 / 3
google
Details
- Product number
- 0054501
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- hepatitidis B viri antigenum ADNr 40 µg, aluminium 0.5 mg ut aluminii hydroxyphosphas sulfas amorphus, borax, natrii chloridum, aqua ad iniectabile q.s. ad suspensionem pro 1 ml corresp. natrium 3.5 mg.
Articles (1)
HBVAXPRO 40, Injektionssuspension
Injektionssuspension
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
40.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
0.5 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
3.5 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 62.20
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
15/03/1997
Authorization holder
MSD Merck Sharp & Dohme AG
6005 Luzern
Authorization information
- Swissmedic authorization number
- 545
- Drug name
- HBVAXPRO 40, Injektionssuspension
- Galenic form
- SUPA
- ATC Code
- J07BC01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 18/04/1988
- Authorization expiration date
- 31/12/9999
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- HBVAXPRO susp inj 40 µg 1 pce
- Description (DE)
- HBVAXPRO Inj Susp 40 µg 1 Stk
- Market launch
- 18/04/1988
- Narcotic (BTM)
- No
Application methods
IMU